Completed his MBBS from Mysore Medical College in 1995 and obtained MD (Medicine) degree from Bangalore Medical College. Completed his DNB (Nephrology) from the National Board of Examinations in 2005 under the guidance of the doyen of Indian Nephrology, Prof JCM Shastry.
Served as a Consultant Nephrologist in Kamineni Hospital, Hyderabad (2005-Feb 2006). Senior Renal Registrar in Flinders Medical Centre, Adelaide, Australia (March 2006-Feb 2008). Consultant and later Head of Dept in Kamineni Hospitals (Mar 2008-Dec 2014). Director, Nephrology in Century Hospital, Hyderabad (Jan 2015-July 2020).
He is presently the Director, Nephrology & Kidney Transplantation, Medicover Hospitals, Telangana since Aug 2020, where he is regarded as a Top Kidney Specialist in Hyderabad, especially for complex kidney transplant cases.
Dr Kamal Kiran is especially passionate about high-risk transplant procedures and is credited with performing India's first ABO incompatibility kidney transplant, along with extensive experience in cross-match positive kidney transplantation.
He also pioneered Hemodiafiltration as an alternative to regular haemodialysis, enhancing outcomes in advanced kidney disease treatment.
He is deeply involved in the study of the genetics of diabetes related kidney diseases, chronic kidney disease (CKD), and transplantation pharmacodynamics.
Relationship of ACE gene polymorphism with nephropathy associated with Type 2 diabetes in Asian Indians.
Read MoreIGF2 ApaI A/G polymorphism as a biomarker for new-onset diabetes mellitus after renal transplant.
Read MoreInfluence of gene polymorphism on calcineurin inhibitor pharmacokinetics in Indian renal transplant patients.
Read MoreExploration of ACE insertion/deletion polymorphism in post-transplant diabetes mellitus.
Read MoreCalpain 10 gene polymorphism in Asian Indians with gestational diabetes mellitus.
Read MoreCorrelation of KCNQ1 & KCNJ11 gene polymorphisms with type 2 and post-transplant diabetes.
Read MoreKidney transplantation from HCV-positive donors to HCV-negative recipients.
Read MoreABO-incompatible kidney transplantation: Indian working group recommendations.
Read MoreInfluence of CYP3A4, CYP3A5 & ABCB1 polymorphisms on tacrolimus levels & rejection risk.
Read More